Moderna raises full-year revenue outlook as third-quarter profit reaches $162 million
Moderna said it now expects full-year revenue growth of 15% to 25%, up from its previous outlook for growth of up to 10%. The company posted a third-quarter profit of $162 million, compared with a $200 million loss a year earlier. Revenue rose 29% to $1.31 billion, exceeding analyst estimates of $890.3 million.